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Use of in silico structure activity relationship (SAR) project in medicinal
chemistry course at Winona State University: Molecular docking simulation and
analysis of human dopamine D3 receptor-rotigotine analog binding
Thomas Provost and Dr. Myoung Lee
Department of Chemistry, Winona State University, Winona, MN 55987

ABSTRACT

METHODS

RESULTS AND DISCUSSION

Medicinal Chemistry is a course offered by Winona State University that focuses on the
chemical structure - biological activity relationship (SAR). The course is offered to
chemistry and biology students who have previously taken organic chemistry and intend
to further their knowledge of pharmacokinetics and pharmacodynamics. Project-based
learning utilizing in silico molecular docking simulations is a primary method to help
students actively learn the concept and the application of the SAR in medicinal
chemistry. A drug target with a known three-dimensional structure is chosen and the
amino acid residues at the binding site of the protein structure were analyzed. A lead
compound was chosen and common modeling programs and lead modification
strategies were employed to change the structure of the lead compound.

Medicinal Chemistry at Winona State is a 2-crecit, upper-level, elective course. No laboratory is required and
the pre-requisite for the course is organic chemistry. This course was offered in fall of 2015 with 15
chemistry and biology majors enrolled. The in silico SAR project was a semester-long project. Several steps
were taken to conduct and analyze the structure activity relationship in the SAR project. These steps were:
1. Disease selection
2. Select a drug target with a known crystal structure/ amino acids identification in the binding site
3. Selection of the lead compound
4. Modification of the lead compound
5. Simulate docking of modified compounds/binding energy and KI
6. Data analysis through interaction tables and binding tables
7. Assessment – oral presentation/paper/final exam

In this presentation, rotigotine analogs and the structure-activity relationship of analog
binding to the human dopamine D3 receptor was analyzed. A single substituent was
modified several times resulting in a definitive relationship of functional groups and their
corresponding binding affinity. It was found that hydrophobic substituents at C1 of
rotigotine increased the binding affinity while electron donating and withdrawing
substituents had little effect.1 This was due to the presence of hydrophobic amino acid
residues at the binding pocket for the C1 substituent. When compared to the original
rotigotine compound, it was found that replacing the original alcohol group on C1 to a
hydrogen increased the binding affinity by ~300%, and by replacing the alcohol with a tBu an increase of ~1,800%; indicating a definitive relationship between the
hydrophobicity of the functional group and the inhibition constant.3

BACKGROUND
Rotigotine is a commonly used anti-tremor drug that is the primary treatment of Parkinson’s
disease (PD) and severe restless-leg syndrome. Rotigotine belongs to a class of drugs known as
dopamine agonists (DA). When rotigotine is absorbed transdermally and travels to the brain, it
crosses the blood brain barrier and binds to human dopamine D3 receptor (3PBL).2 On the specific
3PBL receptors, there are several binding sites that will be analyzed through this research using
molecular docking simulation. The binding sites can be seen in figure two, where the designated
binding site is circled in red. The research focus will be on the binding site of the ligand at the
alcohol on carbon 1 of rotigotine, and to find out what functional groups present in the drug bind
with a higher affinity to the binding site. There are multiple substituents on the rotigotine molecule
that are acceptable to be analyzed. The modification site will have functional groups replacing the
original substituents using a molecular modeling program. The purpose of this research is to find
which functional groups offer a higher binding affinity to different amino acid residues of the 3PBL
receptor that rotigotine targets. Figure one shows the sites that will be modified on the rotigotine
molecule, circled in red.

Figure 5: Through the analysis of log(1/KI) and σ values; it was found that the electron withdrawing
properties of each functional group did not have a strong effect on the binding affinity.1 This
indicates that hydrophobicity is more crucial than electron withdrawing effects in regards to binding
affinity.
The experiment yielded a relationship between π values and log(1/KI), presenting an example of
structure-activity relationship. Unlike π values, a definitive relationship between σ values and
log(1/KI) was not present within the data. It is due to hydrophobic interactions of amino acid
residues within the binding site and the selected substituent. With the presence of Val189 and
Ile183 in the binding site, the KI values for the t-Bu group are explained via the strong hydrophobic
interactions and the high π value for the t-Bu group.

Figure 2: For the protein selection phase of the experiment, the protein 3PBL was selected. 3PBL is a
two-chain, g-protein coupled receptor that binds dopamine within the human dopamine D3 receptor.
It is 481 AA in length.2 For this research, the focus was put on chain A, denoted by the color green.
Figure Three: A simplified dimer of the protein with a rotigotine analogue bound to the receptor,
circled in red.3

Figure 3: To further analyze the relationship of functional
groups and binding affinity, the amino acid residues within
the binding site were analyzed. It can be seen that Val189,
Ile183, His349, Ser192, and Ser193 surround and have
bonding with the carbons of the t-Bu group; the analogue
that had the strongest binding.3

RESULTS AND DISCUSSION

Several relationships were analyzed through the molecular docking server. The primary
objectives of this experiment were to analyze:
1. Functional group interactions at binding site
2. Hydrophobicity and binding strength
3. Amino acid interactions at binding site

FUTURE PLANS
For teaching purposes, this experiment proposes a model for future medicinal
chemistry students to incorporate a higher understanding of SAR. In an effort to
increase the efficiency, future students will use only three ligand modifications with
distinct differences in π and σ values; such as –OH, -H, -t-Bu, and –CF3. A free
subscription for the DockingServer is available for classroom use.
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CONCLUSIONS
Through complete analysis of the data, it was found that the bulkier and more
hydrophobic the functional group, the tighter the binding to 3PBL. This occurs
because of the presence of more hydrophobic amino acid residues within the binding
site. The experiment also yielded a higher understanding of SAR and an opportunity
to create a future project for medicinal chemistry students.

Figure 1: The structure of rotigotine along with the identification of the modification site in red. The
–OH group was selected due to its location within the binding site of the protein. The second figure
is the t-Bu modification that had the highest binding affinity.

OBJECTIVES

Figure 4: By taking the log(1/KI) and plotting each functional groups π value, a plot demonstrating
the hydrophobic effect was constructed.1 A linear relationship was identified with t-Bu being the
bulkiest and hydrophobic, yet binding the tightest of all the functional groups analyzed.
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